Trial Profile
A Randomized Double-Blind Placebo and Active-Controlled Five-Way Crossover Study to Assess the Dose Responsiveness of Methacholine-Induced Bronchial Hyperreactivity to Single Inhaled Doses of Advair® Diskus® in Adult Asthmatics.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Jul 2017
Price :
$35
*
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary) ; Salbutamol
- Indications Asthma
- Focus Therapeutic Use
- 13 Jul 2017 New trial record
- 24 May 2017 Primary endpoint (PC20 value of fluticasone propionate/salmeterol vs placebo) has been met as per the results presented at the 113th International Conference of the American Thoracic Society
- 24 May 2017 Results presented at the 113th International Conference of the American Thoracic Society